Citation Impact
Citing Papers
Review of Studies of Androgen Treatment of Female-to-Male Transsexuals: Effects and Risks of Administration of Androgens to Females
2007
A hexahistidine-Zn 2+ -dye label reveals STIM1 surface exposure
2007 StandoutNobel
Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
2009
The adsorption of prothrombin to phosphatidylserine multilayers quantitated by ellipsometry.
1983
Endocrine care of transpeople part I. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transmen
2015
Thrombin Receptors on Human Platelets
1997
Long-Term Follow-Up of Transsexual Persons Undergoing Sex Reassignment Surgery: Cohort Study in Sweden
2011
γ-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase
1990
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway
1999
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Actin polymerisation regulates thrombin-evoked Ca2+signalling after activation of PAR-4 but not PAR-1 in human platelets
2006
Macrovascular and microvascular endothelium during long‐term hypoxia: Alterations in cell growth, monolayer permeability, and cell surface coagulant properties
1991
Molecular Bases for Circadian Clocks
1999 Standout
Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner
2003
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
5 Thrombophilia: The Discovery of Activated Protein C Resistance
1995
Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats
1987
Miniature, Low‐Dose, Intrauterine Drug‐Delivery Systems
2003
Moojenactivase, a novel pro-coagulant PIIId metalloprotease isolated from Bothrops moojeni snake venom, activates coagulation factors II and X and induces tissue factor up-regulation in leukocytes
2015
The molecular basis of blood coagulation
1988 Standout
Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram
2009
Approach to the Patient: Transgender Youth: Endocrine Considerations
2014
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
2001
Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy
2009
The role of microparticles in the pathogenesis of rheumatic diseases
2009
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
1997 StandoutNature
Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.
1997
Calcium-dependent structural changes in bovine blood coagulation factor Va and its subunits
1989
Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta‐analyses
2009
The coagulation cascade: initiation, maintenance, and regulation
1991 Standout
Vitamin K-dependent Proteins in the Developing and Aging Nervous System
2009
The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine
2008 StandoutNobel
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Mutation in blood coagulation factor V associated with resistance to activated protein C
1994 StandoutNature
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
1993
Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties.
1990
Autoactivation of human recombinant coagulation factor VII
1989
Modulation of monocyte-endothelial cell interactions by platelet microparticles.
1998
Identification of the haemoglobin scavenger receptor
2001 StandoutNature
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
Structure of the first C2 domain of synaptotagmin I: A novel Ca2+/phospholipid-binding fold
1995 StandoutNobel
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
α2A-Adrenergic Receptor Stimulation Potentiates Calcium Release in Platelets by Modulating cAMP Levels
2000
Membrane curvature and mechanisms of dynamic cell membrane remodelling
2005 StandoutNature
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Hormone Treatment of the Adult Transsexual Patient
2005
Interaction of protein kinase C with phosphatidylserine. 2. Specificity and regulation
1992
Extracellular vesicles as drug delivery systems: Lessons from the liposome field
2014
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Annexin VI is required for budding of clathrin-coated pits
1992 StandoutNobel
The plasma hemostatic proteome: thrombin generation in healthy individuals
2005
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions
1998
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Blood Coagulation and Oral Contraceptives
1998
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Interaction of STIM1 with Endogenously Expressed Human Canonical TRP1 upon Depletion of Intracellular Ca2+ Stores
2006
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Molecular cloning and expression of human hepatocyte growth factor
1989 StandoutNature
Comparison of lipid binding and kinetic properties of normal, variant, and .gamma.-carboxyglutamic acid modified human factor IX and factor IXa
1985
Activation of human blood coagulation factor XI independent of factor XII.
1991
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter
2014
Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and d -Phe-Pro-Arg-Ch2Cl
1990
Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders
1988
Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups
1993
Platelet-derived microparticles associate with fibrin during thrombosis
1996
Platelet Microparticles Promote Platelet Interaction With Subendothelial Matrix in a Glycoprotein IIb/IIIa–Dependent Mechanism
1999
Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets.
1990
Complete cDNA and derived amino acid sequence of human factor V.
1987
Hemostatic Effects of Oral Contraceptives in Women who Developed Deep-vein Thrombosis while Using Oral Contraceptives
1998
Long-Term Follow-Up of Individuals Undergoing Sex-Reassignment Surgery: Somatic Morbidity and Cause of Death
2016
Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro
2005 StandoutNobel
People with Gender Dysphoria Who Self-Prescribe Cross-Sex Hormones: Prevalence, Sources, and Side Effects Knowledge
2014
Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273.
1986
Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia
1997 StandoutNobel
Inherited Thrombophilia: Part 1
1996
Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) [see comments]
1995
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation
2001
Mechanical constraint imposed on plasma membrane through transverse phospholipid imbalance induces reversible actin polymerization via phosphoinositide 3-kinase activation
2003
Long-Term Treatment of Transsexuals with Cross-Sex Hormones: Extensive Personal Experience
2007
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
1999 Standout
The Dynamics of Thrombin Formation
2003
Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles.
1991
Noncardiovascular disease outcomes during 6.8 years of hormone therapy. heart and estrogen/progestin replacement study follow-up (HERS II)
2002
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.
1989
Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism.
1987
Platelet-derived microparticles express high affinity receptors for factor VIII.
1991
The interactions between inflammation and coagulation
2005
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Thrombin-catalyzed activation of human coagulation factor V.
1982
Cross-Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short-Time Follow-Up: Results from the European Network for the Investigation of Gender Incongruence
2014
Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation
1987
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review
2013
Recombinant human protein C, protein S and thrombomodulin as antithrombotics
1994
The protein C anticoagulant pathway.
1992
Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles
1992
Cell-Derived Microparticles Generated in Patients During Cardiopulmonary Bypass Are Highly Procoagulant
1997
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Oxidized Redox State of Glutathione in the Endoplasmic Reticulum
1992 StandoutScience
The limited importance of factor Xa inhibition to the anticoagulant property of heparin in thromboplastin-activated plasma
1988
Inherited resistance to activated protein C iscorrected by anticoagulant cofactor activity found to be a property of factorV.
1994
Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells
1997
Formation of a calcium-binding site on bovine activated factor V following recombination of the isolated subunits.
1982
Venous thrombosis: a multicausal disease
1999 Standout
cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family.
1989 StandoutNobel
An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cage
1986
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII
1990
A Reduced Sensitivity for Activated Protein C in the Absence of Factor V Leiden Increases the Risk of Venous Thrombosis
1999
Suppression of TNF-α-Induced Apoptosis by NF-κB
1996 StandoutScience
Lys49 myotoxin from the Brazilian lancehead pit viper elicits pain through regulated ATP release
2017 StandoutNobel
Recent Epidemiological Studies of the Association Between Hormone Replacement Therapy and Venous Thromboembolism
1998
Prothrombin Loading of Vascular Smooth Muscle Cell–Derived Exosomes Regulates Coagulation and Calcification
2017
Works of Jan Rosing being referenced
[Effects of second and third generation oral contraceptives on hemostasis].
2001
The role of phospholipid and factor VIIIa in the activation of bovine factor X.
1981
Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C
1995
Total chemical synthesis of human matrix Gla protein
2001
Structural and fuctional characterization of a prothrombin activator from the venom of Bothrops neuwiedi
1987
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives
1997
The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C
1992
Prothrombin activation on phospholipid membranes with positive electrostatic potential
1988
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study
1999
Oral Contraceptives and the Risk of Venous Thrombosis
2001
Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance
1989
Coagulation factors and the protein C system as determinants of thrombin generation in a normal population
2008
The Ca2+‐Mobilizing Potency of α‐Thrombin and Thrombin‐Receptor‐Activating Peptide on Human Platelets
1997
Prothrombin activation on membranes with anionic lipids containing phosphate, sulfate and/or carboxyl groups
1990
Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on formation of the enzyme-substrate complex
1984
Protein S binds to and inhibits factor Xa.
1994
Increased Fibrinolytic Activity during Use of Oral Contraceptives Is Counteracted by an Enhanced Factor XI-independent down Regulation of Fibrinolysis
2000
Simple and rapid method to determine the binding of blood clotting factor X to phospholipid vesicles
1981
Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition
1982
Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).
1983
Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake).
1986
The role of phospholipids and factor Va in the prothrombinase complex.
1980
Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation.
1986
The role of activated human platelets in prothrombin and factor X activation
1985
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial
2003
Rapid activation of haemostasis after hormonal emergency contraception
2007
Autoactivation of human plasma prekallikrein.
1987
Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than α-thrombin
1996
Venous Thrombosis and Changes of Hemostatic Variables during Cross-Sex Hormone Treatment in Transsexual People
2003
Purification and properties of a prothrombin activator from the venom of Notechis scutatus scutatus.
1985
Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C.
1993
Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles
1991